INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
Practical guide · October 2026

CoreAge Rx and Membership Programs: Compare the Same Purchase

A medication-focused starting rate and a care membership describe different bills and different product choices.

Read this firstSources checked October 7, 2026

Compare purchase models explicitly: a promotional medication offer and a separate care membership are not the same item.

CoreAge promotion
$79 / $129

Medicine-specific promotional figures; confirm selected order terms.

Ro membership
$39 initially

Ongoing membership and medication have separate charges.

Noom branded membership
$39 initially

Then $129/mo billed quarterly; medication excluded.

CoreAge Rx advertises compounded semaglutide from $79 per month and compounded tirzepatide from $129, with no membership fee on the linked promotional page. A program that charges for membership first may look similar in a price table while selling a different combination of services and medicine.

The comparison becomes useful when the preparation, included care and actual payment are named together. This guide follows CoreAge Rx, Ro and Noom’s published descriptions without treating their lowest figures as prices for identical treatments or as evidence that one program produces better outcomes.

The details, visualized

Three published prices with three different scopes

A practical decision map; not a clinical score

  1. CoreAge promotion$79 / $129

    Medicine-specific promotional figures; confirm selected order terms.

  2. Ro membership$39 initially

    Ongoing membership and medication have separate charges.

  3. Noom branded membership$39 initially

    Then $129/mo billed quarterly; medication excluded.

Use the source documents and your selected agreement. A public description does not determine personal treatment eligibility.

View the printable chart imageThree published prices with three different scopes. The same values and context are available in the data table above.
Research note 01

Compare the work done by each payment

CoreAge’s promotional page describes medicine-specific figures without a separate membership fee. Ro and Noom’s branded-medication route use a recurring care membership beside the medicine charge. A meaningful comparison asks what clinical contact, paperwork and pharmacy access the payment purchases, rather than sorting those three headline amounts.

Use the same proposed medicine and period wherever possible. If one route involves a compounded preparation and another an approved branded product, retain that difference in the comparison. A lower published number does not establish interchangeability, personal suitability or an identical service.

Before you decide

Questions worth answering

How should I use the chart on this page?

Use the source documents and your selected agreement. A public description does not determine personal treatment eligibility.

What should I keep after comparing my options?

Save the named product, the relevant source or agreement, the full payment and renewal details, and the clinician or pharmacy contact. Use the chart as an organizer for questions; it does not replace the selected contract or a medical assessment.

Evidence behind this page

Sources & chart notes

Checked October 7, 2026. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
CoreAge Rx and Membership Programs: Compare the Same Purchase — keep the exact product identity and its complete label together.

Start with the medicine, then the service

CoreAge Rx’s named product pages describe US-compounded preparations, online physician evaluation and free delivery. Ro’s pricing page separates membership from FDA-approved medicines. Noom’s pricing page contains both medicine-inclusive programs and a branded-medication telehealth option that excludes the drug cost. These are meaningful product and billing differences.

A shared ingredient name does not remove the approval distinction. FDA says compounded GLP-1 preparations are not approved finished drugs and do not undergo its premarket review for safety, effectiveness and quality. The treatment guide keeps that question separate from the price of clinical access.

Editorial illustration: a telehealth screen, a question card and an unbranded container.
Start with the medicine, then the service — keep the product information and the route for asking a question in the same comparison.

Compare complete bills rather than entry figures

Ro advertises $39 for the first membership month, then different continuing rates according to the selected plan; medicine is another charge. Noom’s branded telehealth option advertises $39 initially and $129 per month afterward, billed quarterly, excluding medication. Neither entry figure is a complete medication-inclusive total.

CoreAge’s $79 and $129 promotional rates are starting advertisements tied to different compounded medicines. Its separate policy says the selected plan may be one-time or automatically renewing, with material terms presented at purchase. The cost guide helps retain the full selected quote rather than assuming the product headline answers every financial question.

Continuing contact deserves its own description

CoreAge describes ongoing provider access; Ro’s membership names on-demand provider support. Noom describes clinical access alongside its digital program, coaching and other tools. Those features can make a service useful, but advertised availability is not a response time measured by this publication.

The relevant comparison is which professional or team handles a clinical concern, an account issue or a pharmacy question. A large feature list is not proof that every contact performs the same role. The contact guide separates those responsibilities without claiming an individual handoff was completed.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
Continuing contact deserves its own description — keep the exact product identity and its complete label together.

Flexibility requires the written term

CoreAge’s cancellation policy says stopping future renewals does not automatically refund an order already processed or submitted for pharmacy fulfillment. Ro offers prepaid membership choices as well as a monthly plan. Noom’s quarterly billing creates another payment interval. A monthly-looking rate does not settle those commitments.

Read the CoreAge Rx, Ro and Noom Med reviews for each offer’s context. The useful decision record holds the medicine, full bill, contact model and renewal terms together. It does not use a no-membership headline or a program feature as a clinical recommendation.

Compare the purchase and refill choices

Read Best weight loss injection plans by complete invoice and Best semaglutide injection plans to compare before refilling to put this guide beside specific provider models.

Use the offer details

Open the CoreAge Rx review, GLP-1 program index, and cost table to continue your comparison. Medical suitability should be discussed with a licensed clinician.

Research record

Documents used

Source register refreshed October 7, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.

  1. CoreAge Rx semaglutide product ↗
  2. CoreAge Rx tirzepatide product ↗
  3. CoreAge Rx purchase and refund policy ↗
  4. Ro membership and medication pricing ↗
  5. Noom program pricing ↗
  6. FDA compounded GLP-1 concerns ↗